{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:44:52Z","timestamp":1793659492256,"version":"4.5.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T00:00:00Z","timestamp":1444694400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12916-015-0452-y","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T17:13:09Z","timestamp":1443719589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study"],"prefix":"10.1186","volume":"13","author":[{"given":"Marc","family":"Baguelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Flasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. John","family":"Edmunds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,13]]},"reference":[{"key":"452_CR1","volume-title":"Influenza Vaccines \u2013 WHO Position Paper","author":"World Health Organisation","year":"2005","unstructured":"World Health Organisation. Influenza Vaccines \u2013 WHO Position Paper. Geneva: WHO; 2005."},{"key":"452_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.15.44.19700-en","volume":"15","author":"J Mereckiene","year":"2010","unstructured":"Mereckiene J, Cotter S, D\u2019Ancona F, Giambi C, Nicoll A, L\u00e9vy-Bruhl D, et al. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008\u20132009. Eurosurveillance. 2010;15:1\u201310.","journal-title":"Eurosurveillance."},{"key":"452_CR3","volume-title":"Weekly epidemiological record","author":"World Health Organisation","year":"2012","unstructured":"World Health Organisation. Weekly epidemiological record, vol. 87. Geneva: WHO; 2012. 21 (pp 201\u2013216)."},{"key":"452_CR4","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1016\/j.vaccine.2008.06.101","volume":"26","author":"E Vynnycky","year":"2008","unstructured":"Vynnycky E, Pitman R, Siddiqui R, Gay N, Edmunds WJ. Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine. 2008;26:5321\u201330.","journal-title":"Vaccine."},{"key":"452_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/aje\/kwp237","volume":"170","author":"NE Basta","year":"2009","unstructured":"Basta NE, Chao DL, Halloran ME, Matrajt L, Longini IM. Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. Am J Epidemiol. 2009;170:679\u201386.","journal-title":"Am J Epidemiol."},{"key":"452_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nature06732","volume":"452","author":"S Cauchemez","year":"2008","unstructured":"Cauchemez S, Valleron A-J, Bo\u00eblle P-Y, Flahault A, Ferguson NM. Estimating the impact of school closure on influenza transmission from Sentinel data. Nature. 2008;452:750\u20134.","journal-title":"Nature."},{"key":"452_CR7","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1016\/j.vaccine.2012.03.019","volume":"30","author":"M Baguelin","year":"2012","unstructured":"Baguelin M, Jit M, Miller E, Edmunds WJ. Health and economic impact of the seasonal influenza vaccination programme in England. Vaccine. 2012;30:3459\u201362.","journal-title":"Vaccine."},{"key":"452_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.2010.250","volume":"303","author":"M Loeb","year":"2010","unstructured":"Loeb M, Russell ML, Moss L, Fonseca K, Fox J, Earn DJD, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA. 2010;303:943\u201350.","journal-title":"JAMA."},{"key":"452_CR9","doi-asserted-by":"publisher","first-page":"e1001527","DOI":"10.1371\/journal.pmed.1001527","volume":"10","author":"M Baguelin","year":"2013","unstructured":"Baguelin M, Flasche S, Camacho A, Demiris N, Miller E, Edmunds WJ. Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med. 2013;10:e1001527.","journal-title":"PLoS Med."},{"key":"452_CR10","unstructured":"JCVI statement on the annual influenza vaccination programme \u2013 extension of the programme to children. 2012. http:\/\/webarchive.nationalarchives.gov.uk\/20130402145952\/http:\/\/media.dh.gov.uk\/network\/261\/files\/2012\/07\/jcvi-statement-on-the-annual-influenza-vaccination-programme-25-july-2012.pdf ."},{"key":"452_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jinf.2013.11.013","volume":"68","author":"D Cromer","year":"2014","unstructured":"Cromer D, van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy. J Infect. 2014;68:363\u201371.","journal-title":"J Infect"},{"key":"452_CR12","unstructured":"National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. 2013. https:\/\/www.nice.org.uk\/article\/pmg9\/chapter\/foreword ."},{"key":"452_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/aje\/kwm375","volume":"167","author":"F Carrat","year":"2008","unstructured":"Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775\u201385.","journal-title":"Am J Epidemiol."},{"key":"452_CR14","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0140-6736(13)62433-2","volume":"382","author":"A Camacho","year":"2013","unstructured":"Camacho A, Eames K, Adler A, Funk S, Edmunds J. Estimation of the quality of life effect of seasonal influenza infection in the UK with the internet-based Flusurvey cohort: an observational cohort study. Lancet. 2013;382:S8.","journal-title":"Lancet."},{"key":"452_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1471-2334-14-232","volume":"14","author":"AJ Adler","year":"2014","unstructured":"Adler AJ, Eames KTD, Funk S, Edmunds WJ. Incidence and risk factors for influenza-like-illness in the UK: online surveillance using Flusurvey. BMC Infect Dis. 2014;14:232.","journal-title":"BMC Infect Dis."},{"key":"452_CR16","doi-asserted-by":"crossref","unstructured":"Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer G a, Al-Ansary L A, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2010;(7):CD001269.","DOI":"10.1002\/14651858.CD001269.pub4"},{"key":"452_CR17","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/jech.2009.093450","volume":"64","author":"DM Fleming","year":"2010","unstructured":"Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health. 2010;64:1062\u20137.","journal-title":"J Epidemiol Community Health."},{"key":"452_CR18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.vaccine.2008.11.093","volume":"27","author":"J Rhorer","year":"2009","unstructured":"Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine. 2009;27:1101\u201310.","journal-title":"Vaccine."},{"key":"452_CR19","unstructured":"National Health Service England. Enhanced Services Specification: Seasonal Influenza and Pneumococcal Immunisation Enhanced Service. 2014. http:\/\/www.england.nhs.uk\/wp-content\/uploads\/2014\/06\/flu-pneumo-immu-spec.pdf ."},{"key":"452_CR20","unstructured":"National Health Service England. General Medical Services Statement of Financial Entitlements Directions 2014. 2014. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/299591\/SFE_amend_directions_2014.pdf ."},{"key":"452_CR21","doi-asserted-by":"publisher","first-page":"e17030","DOI":"10.1371\/journal.pone.0017030","volume":"6","author":"AJ Hoek Van","year":"2011","unstructured":"Van Hoek AJ, Underwood A, Jit M, Miller E, Edmunds WJ. The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study. PLoS One. 2011;6:e17030.","journal-title":"PLoS One."},{"key":"452_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3201\/eid1402.070478","volume":"14","author":"MR Siddiqui","year":"2008","unstructured":"Siddiqui MR, Edmunds WJ. Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic. Emerg Infect Dis. 2008;14:267\u201374.","journal-title":"Emerg Infect Dis."},{"key":"452_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1023\/B:EJEP.0000024752.48929.bd","volume":"19","author":"A Melegaro","year":"2004","unstructured":"Melegaro A, Edmunds WJ. The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales. Eur J Epidemiol. 2004;19:365\u201375.","journal-title":"Eur J Epidemiol"},{"key":"452_CR24","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/bmj.316.7133.736","volume":"316","author":"P Kind","year":"1998","unstructured":"Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998;316:736\u201341.","journal-title":"BMJ."},{"key":"452_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S2213-2600(14)70034-7","volume":"2","author":"AC Hayward","year":"2014","unstructured":"Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds WJ, et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med. 2014;2:445\u201354.","journal-title":"Lancet Respir Med."},{"key":"452_CR26","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","volume":"5","author":"J Mossong","year":"2008","unstructured":"Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5:e74.","journal-title":"PLoS Med."},{"key":"452_CR27","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.vaccine.2010.01.002","volume":"28","author":"M Baguelin","year":"2010","unstructured":"Baguelin M, Van Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ. Vaccination against pandemic influenza A\/H1N1v in England: a real-time economic evaluation. Vaccine. 2010;28:2370\u201384.","journal-title":"Vaccine."},{"key":"452_CR28","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17:873\u201390.","journal-title":"Stat Med."},{"key":"452_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1753-6405.2010.00639.x","volume":"35","author":"V Mogasale","year":"2011","unstructured":"Mogasale V, Barendregt J. Cost-effectiveness of influenza vaccination of people aged 50-64 years in Australia: results are inconclusive. Aust N Z J Public Health. 2011;35:180\u20136.","journal-title":"Aust N Z J Public Health."},{"key":"452_CR30","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.1016\/j.vaccine.2010.09.053","volume":"28","author":"KJ Smith","year":"2010","unstructured":"Smith KJ, Lee BY, Nowalk MP, Raymund M, Zimmerman RK. Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds. Vaccine. 2010;28:7620\u20135.","journal-title":"Vaccine."},{"key":"452_CR31","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.vaccine.2008.01.050","volume":"26","author":"AT Newall","year":"2008","unstructured":"Newall AT, Scuffham PA, Kelly H, Harsley S, Macintyre CR. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia. Vaccine. 2008;26:2142\u201353.","journal-title":"Vaccine."},{"key":"452_CR32","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.1016\/j.vaccine.2007.07.033","volume":"25","author":"S Aball\u00e9a","year":"2007","unstructured":"Aball\u00e9a S, De Juanes JR, Barbieri M, Martin M, Chancellor J, Oyag\u00fcez I, et al. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain. Vaccine. 2007;25:6900\u201310.","journal-title":"Vaccine."},{"key":"452_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1524-4733.2006.00157.x","volume":"10","author":"S Aball\u00e9a","year":"2007","unstructured":"Aball\u00e9a S, Chancellor J, Martin M, Wutzler P, Carrat F, Gasparini R, et al. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. Value Health. 2007;10:98\u2013116.","journal-title":"Value Health."},{"key":"452_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1001\/archpediatrics.2010.182","volume":"165","author":"LA Prosser","year":"2011","unstructured":"Prosser LA, Meltzer MI, Fiore A, Epperson S, Bridges CB, Hinrichsen V, et al. Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years. Arch Pediatr Adolesc Med. 2011;165:112\u20138.","journal-title":"Arch Pediatr Adolesc Med."},{"key":"452_CR35","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1016\/j.vaccine.2009.01.053","volume":"27","author":"L Salleras","year":"2009","unstructured":"Salleras L, Navas E, Dom\u00ednguez A, Ib\u00e1\u00f1ez D, Prat A, Garrido P, et al. Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3-14 years during the annual health examination in private paediatric offices. Vaccine. 2009;27:3454\u20138.","journal-title":"Vaccine."},{"key":"452_CR36","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1016\/j.vaccine.2008.03.046","volume":"26","author":"BR Luce","year":"2008","unstructured":"Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, et al. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Vaccine. 2008;26:2841\u20138.","journal-title":"Vaccine."},{"key":"452_CR37","doi-asserted-by":"publisher","first-page":"w96","DOI":"10.1377\/hlthaff.27.2.w96","volume":"27","author":"J Schmier","year":"2008","unstructured":"Schmier J, Li S, King JC, Nichol K, Mahadevia PJ. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial. Health Aff (Millwood). 2008;27:w96\u2013104.","journal-title":"Health Aff (Millwood)"},{"key":"452_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2165\/00019053-200826010-00005","volume":"26","author":"R Pradas-Velasco","year":"2008","unstructured":"Pradas-Velasco R, Anto\u00f1anzas-Villar F, Mart\u00ednez-Z\u00e1rate MP. Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination. Pharmacoeconomics. 2008;26:45\u201356.","journal-title":"Pharmacoeconomics."},{"key":"452_CR39","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1016\/j.vaccine.2007.09.018","volume":"25","author":"CL Hibbert","year":"2007","unstructured":"Hibbert CL, Piedra PA, McLaurin KK, Vesikari T, Mauskopf J, Mahadevia PJ. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine. 2007;25:8010\u201320.","journal-title":"Vaccine."},{"key":"452_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4161\/hv.3.1.3657","volume":"3","author":"M Marchetti","year":"2007","unstructured":"Marchetti M, K\u00fchnel UM, Colombo GL, Esposito S, Principi N. Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age. Hum Vaccin. 2007;3:14\u201322.","journal-title":"Hum Vaccin."},{"key":"452_CR41","doi-asserted-by":"publisher","first-page":"e1000256","DOI":"10.1371\/journal.pmed.1000256","volume":"7","author":"B Sander","year":"2010","unstructured":"Sander B, Kwong JC, Bauch CT, Maetzel A, McGeer A, Raboud JM, et al. Economic appraisal of Ontario\u2019s Universal Influenza Immunization Program: a cost-utility analysis. PLoS Med. 2010;7:e1000256.","journal-title":"PLoS Med."},{"key":"452_CR42","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1016\/j.vaccine.2013.09.013","volume":"31","author":"SK Peasah","year":"2013","unstructured":"Peasah SK, Azziz-Baumgartner E, Breese J, Meltzer MI, Widdowson M-A. Influenza cost and cost-effectiveness studies globally \u2013 a review. Vaccine. 2013;31:5339\u201348.","journal-title":"Vaccine."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0452-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-015-0452-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0452-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T04:57:13Z","timestamp":1567227433000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-015-0452-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,13]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["452"],"URL":"https:\/\/doi.org\/10.1186\/s12916-015-0452-y","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,13]]},"article-number":"236"}}